Scarica l'app Stockscreener
3.035
0.49%
-0.015
Dopo l'orario di chiusura:
3.04
0.005
+0.16%
Precedente Chiudi:
$3.05
Aprire:
$3.03
Volume 24 ore:
276.55K
Relative Volume:
0.43
Capitalizzazione di mercato:
$240.15M
Reddito:
$130.42M
Utile/perdita netta:
$18.64M
Rapporto P/E:
13.91
EPS:
0.2182
Flusso di cassa netto:
$4.05M
1 W Prestazione:
-2.41%
1M Prestazione:
-0.49%
6M Prestazione:
-41.86%
1 anno Prestazione:
-68.39%
Intervallo 1D:
$3.00
$3.065
Intervallo di 1 settimana:
$3.00
$3.18
Portata 52W:
$2.87
$10.52
Niagen Bioscience Inc Stock (NAGE) Company Profile
Nome
Niagen Bioscience Inc
Settore
Industria
Telefono
310-388-6706
Indirizzo
10900 WILSHIRE BLVD, LOS ANGELES
Compare NAGE vs VRTX, REGN, ARGX, MRNA, RVMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NAGE
Niagen Bioscience Inc
|
3.035 | 241.33M | 130.42M | 18.64M | 4.05M | 0.2182 |
VRTX
Vertex Pharmaceuticals Inc
|
514.56 | 132.08B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
793.26 | 83.15B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
984.04 | 62.71B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
136.62 | 54.14B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
203.35 | 44.51B | 742.00K | -1.37B | -1.07B | -7.0731 |
Niagen Bioscience Inc Stock (NAGE) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-05-27 | Iniziato | Canaccord Genuity | Buy |
| 2022-08-16 | Downgrade | Oppenheimer | Outperform → Perform |
| 2022-08-11 | Downgrade | B. Riley Securities | Buy → Neutral |
| 2022-03-08 | Iniziato | ROTH Capital | Buy |
| 2019-10-16 | Iniziato | Oppenheimer | Outperform |
| 2019-02-14 | Iniziato | B. Riley FBR | Buy |
| 2017-11-27 | Ripresa | H.C. Wainwright | Buy |
| 2017-09-25 | Iniziato | Ladenburg Thalmann | Buy |
| 2017-01-03 | Iniziato | Rodman & Renshaw | Buy |
Mostra tutto
Niagen Bioscience Inc Borsa (NAGE) Ultime notizie
Niagen Bioscience to Present at Canaccord Genuity’s Well Summit - Business Wire
Niagen Bioscience, Inc. (NASDAQ: NAGE) Share Price, NAGE Stock News, NAGE Share Price & Updates - Kalkine
Niagen Bioscience to Present at Longevity Investors Conference - Business Wire
Niagen Bioscience, Inc. (NASDAQ:NAGE) Given Average Recommendation of "Buy" by Brokerages - MarketBeat
NAGE Price History for Niagen Bioscience Stock - Barchart.com
Niagen Bioscience at Midwest IDEAS: cash-rich growth and drug bets - Investing.com India
Niagen Bioscience to Present at Nasdaq X LD Micro Inaugural SF Summit - Yahoo Finance
Niagen (NAGE) Results at a Glance: Profit Per Share Falls Below Its Benchmark in Latest Trading; Market Response - vinanet.vn
Niagen Bioscience stock gains GNC, Sam’s Club distribution, Canaccord reiterates buy - Investing.com
Niagen Bioscience Leads The Way With 2 Promising Penny Stocks - Sahm
Supplement Retail Expansions - Trend Hunter
Niagen Bioscience expands Tru Niagen to GNC, Sam’s Club stores - Investing.com
Niagen Bioscience expands Tru Niagen to GNC, Sam’s Club stores By Investing.com - Investing.com India
Niagen Bioscience Expands Tru Niagen® Retail Footprint with GNC and Sam’s Club - New Castle News
Tieton Capital Management LLC Purchases New Position in Niagen Bioscience, Inc. $NAGE - MarketBeat
Niagen (NAGE) Results at a Glance: EPS Does Not Reach the Reported Estimate for the Current Session; Price Reaction: The Stock Gains 4.71%Earnings Stability Report - vinanet.vn
Niagen (NAGE): Closes 0.33% Higher at $3.05 on the Day; Range and Risk: the Supplied Trading Band Runs From $2.90 to $3.20 on the DayAndrews Pitchfork - vinanet.vn
Niagen Bioscience (NAGE) Eases to $3.02 as Support Level Comes into FocusLong Term Entry Picks - Vinanet
Niagen Bioscience (NAGE) Holds Above $2.9 Support as Shares Drift LowerArms Index - vinanet.vn
Niagen Bioscience to Present at Midwest IDEAS Investor Conference - Bitget
Niagen Bioscience at canaccord growth conference: cash, science and growth By Investing.com - Investing.com India
Niagen Bioscience at canaccord growth conference: cash, science and growth - Investing.com
Does Niagen Bioscience's (NAGE) Walmart NAD+ Push Redefine Its Healthy‑Aging Brand Narrative? - Yahoo Finance
HC Wainwright Forecasts Lower Earnings for Niagen Bioscience - MarketBeat
Niagen Bioscience, Inc. (NAGE) Stock Analysis: A 297% Upside Potential Awaits Investor Attention - DirectorsTalk Interviews
Is Niagen Bioscience (NAGE) Quietly Recasting Its Brand Around E‑Commerce Scale And Clinical Proof - simplywall.st
Niagen Bioscience launches Tru Niagen on Walmart.com - Investing.com India
HC Wainwright Predicts Weaker Earnings for Niagen Bioscience - MarketBeat
Niagen Bioscience Launches Tru Niagen on Walmart.com, Expanding Access and Diversifying Its E-commerce Marketplace Presence - Yahoo Finance
NAGE Stock Price and Chart — NASDAQ:NAGE - TradingView
Sei Investments Co. Increases Holdings in Niagen Bioscience, Inc. $NAGE - marketbeat.com
Niagen Bioscience, Inc. $NAGE Holdings Boosted by Renaissance Technologies LLC - MarketBeat
Niagen Bioscience (NAGE) On New Aging Study And The Case For A Higher Fair Value - Yahoo Finance
Niagen Bioscience (NAGE) Stock Sinks As Profit Cushion Thins - simplywall.st
Q2 2026 Niagen Bioscience Inc Earnings Call Transcript - GuruFocus
CCORF Maintains Niagen Bioscience(NAGE.US) With Buy Rating, Maintains Target Price $10 - Moomoo
Niagen Bioscience, Inc. (NASDAQ:NAGE) Given Consensus Rating of "Buy" by Brokerages - MarketBeat
Niagen Bioscience Inc (NAGE) (Q2 2026) Earnings Call Highlights: - GuruFocus
Niagen Bioscience, Inc. Stock 12‑Month Price Target Cut to $12.08, Implies 248% Upside - TradingView
Earnings call transcript: Niagen Bioscience posts q2 2026 growth, lifts spending - Investing.com Canada
Niagen Bioscience (NASDAQ:NAGE) Announces Quarterly Earnings Results, Meets Expectations - MarketBeat
Is Niagen Bioscience Inc (NAGE) Undervalued After Q2 Earnings Mi - GuruFocus
Niagen Bioscience (NAGE) Meets Q2 Earnings Estimates - Yahoo Finance
Niagen Bioscience, Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:NAGE) 2026-08-04 - Seeking Alpha
Niagen Bioscience Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Niagen Bioscience: Q2 Earnings Snapshot - Barchart.com
Niagen Bioscience, Inc. (NAGE) Q2 FY2026 earnings call transcript - Yahoo Finance
Niagen Bioscience 2026: Revenue $29.79M, EPS $0.01— 10-Q Summary - TradingView
Press Release: Niagen Bioscience, Inc. Reports Second Quarter 2026 Financial Results - 富途牛牛
[10-Q] Niagen Bioscience, Inc. Quarterly Earnings Report - Stock Titan
Niagen Bioscience, Inc. Reports Second Quarter 2026 Financial Results - Yahoo Finance
Niagen Bioscience Inc Azioni (NAGE) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.04%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):